Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment
Three interconnected processes in glioblastoma (GBM) biology: initiation, stratification, and immunosuppression. 1) Initiation: GBM initiation is proposed to occur through migration of TERT mutation‐bearing neural stem cells from the subventricular zone to the frontal and temporal cortices, where a subsequent oncogenic transformation drives their ...
Emerson Achari +6 more
wiley +1 more source
Loss of EPB41L3: a common molecular link in the tumorigenesis of neurofibromatosis types 1 and 2. [PDF]
Tao E +12 more
europepmc +1 more source
Selumetinib as a Target Therapy in Progressive Paediatric Low‐Grade Gliomas—Case Series (pLGG)
ABSTRACT Background Optic pathway gliomas (OPGs) occur in 15%–20% of children with neurofibromatosis type 1 (NF1). While smaller gliomas may be only monitored, the current standard of care for symptomatic ones relies on chemotherapy, most commonly carboplatin and vincristine.
Laura Trapani +12 more
wiley +1 more source
Ultrasonography for Surgical Planning and Follow-Up in Neurofibromatosis Type 1. [PDF]
Shen PY +4 more
europepmc +1 more source
Uveal and retinal abnormalities in an Asian neurofibromatosis type 1 cohort: a cross-sectional study with age-stratified analysis. [PDF]
Guo S +13 more
europepmc +1 more source
Spontaneous arterial rupture complicating neurofibromatosis type 1: a case report of massive lumbogluteal hematoma and literature review. [PDF]
Zhang J, Pang X, Meng Y, Sun Q.
europepmc +1 more source
Induced pluripotent stem cell-derived models of malignant nerve sheath tumor progression mimic glial to neuro-mesenchymal transition and uncover therapeutic opportunities. [PDF]
Uriarte-Arrazola I +19 more
europepmc +1 more source
Diagnoses of double heterozygous NF1 variants and dual RASopathy. [PDF]
Angelova-Toshkina D +6 more
europepmc +1 more source
An Isolated Colonic Neurofibroma Without Systemic Neurofibromatosis: A Rare Case Report and Literature Review. [PDF]
Alessa HA +10 more
europepmc +1 more source

